Special Committee Meeting on Medical Cannabis Committee Chair

Total Page:16

File Type:pdf, Size:1020Kb

Special Committee Meeting on Medical Cannabis Committee Chair Special Committee Meeting on Medical Cannabis Committee Chair Baker and committee members. Thank you for hearing this very important topic on medical cannabis. I very much want to talk to you today from the viewpoint of a cannabis nurse who knows the medical potential of plant therapy and the subsequent improvement in quality of life that many patients across Kansas will experience once they have access to medical cannabis. I must make it clear that I am for controlled medical access not recreational use. Many cannabis supporters who are medical professionals across the state have been in the past, reluctant to speak up about cannabis. The stigma tied to “marijuana” (cannabis) use is being lifted and we are no longer willing to stand by in silence while patients suffer. I have reached out to hundreds of nurses in Kansas and the majority support medical cannabis use. Science verifies that Cannabis offers us a legitimate alternative to pharmaceutical products to treat medical conditions. It has been used for over 4000 years safely worldwide. Research and technology tell us cannabis should not be categorized as schedule one for many reasons, the most important being it does have accepted medical use. Since the beginning of prohibition truthful information about cannabis has been suppressed. The Federal government has provided and still does provide cannabis to glaucoma patients, (two on the program are still alive and continue to receive pre-rolled cannabis cigarettes) and the Federal Government has had a patent on CBD since 2003. If the Federal government acknowledges the benefits of cannabis, why can’t Kansas? What I am asking you to do today is to include input from cannabis educated medical professionals when formulating any cannabis legislation. We offer patient centered considerations that may be overlooked by those not familiar with how medical cannabis is being used for healing. Raw cannabis, dried cannabis, flowers and leaves of the plant are critical for treating many illnesses and science supports this. There are a lot of critical considerations you will be asked to make about this issue and sadly you will have to sift through negative personal bias and statements that are made to protect those who stand to lose or make a lot of money if Kansans laws change. We have a unique opportunity being one of the last states in the union to formulate medical cannabis legislation. We are being afforded the opportunity to examine what is working in other states as well as what is not working and come up with amazing legislation that is truly focused on patients. I would like to explain what a cannabis nurse is. First and foremost, we are patient advocates. We strive to advance excellence in cannabis nursing practice through advocacy, collaboration, education, research and policy development. Cannabis nurses have advanced training in the endocannabinoid system and its functions, cannabis products and their use, dosage guidelines, safety while using cannabis, drug interactions, standards of practice, and we offer cannabis education to other medical professionals and general public. Thousands of nurses across the nation have formed professional cannabis nursing organizations. We attend and present National Symposium on cannabis, review medical studies, learn from scientists, researchers and physicians about the latest studies and trends in the industry. Our knowledge base is strictly backed by science and our organizations are led by nurses. Physicians, and nurses have clear standards of practice and continue developing cannabis use guidelines. We offer cannabis education, and act as a resource for patients, other medical professionals and are developing college curriculums for medical and nursing students relating to the endocannabinoid system. Many of us are involved in cannabis product development, formulation, sales and have developed patient centered businesses like care clinics. Kansas will realize many business opportunities that will encompass every aspect of this industry, from seed to sale including patient care when cannabis for medical use is legalized. Therefore, we feel strongly that you involve cannabis knowledgeable nurses and physicians when laws are being formulated. We know what patients need. There are a couple of key points I would like to make about cannabis with the first being that we must understand cannabis is an herb. Herbal products work differently in our bodies than single pharmacologically active substances. Herbal drugs are considered less potent than prescribed medicines. The latter usually contain one highly concentrated active ingredient(s), while herbs may have several active ingredients that are chemically similar. Scientific research supports that cannabis has over 425 known compounds that are contained within the plant. Because we are uniquely individual, how one person responds to herbal plant products does not necessarily mean another person will respond in exactly the same way. Secondly, the most important point I can make today is that using cannabis as medicine is NOT about being intoxicated, it’s about triggering the endocannabinoid system we all have within our bodies and relieving symptoms. This is important when we look at restricting amounts of cannabis that might be allowed. Patients that are using cannabis for pain control in a hospice setting will require a much higher dose than someone who uses it for arthritis or inflammatory problems. We must also take into consideration that raw cannabis has its medicinal value too. Raw forms of cannabis are nutritious and NON-intoxicating. Cannabis has long been recognized as a nutrition herb and in the past was grown in gardens throughout the US. Patients must be allowed to grow a limited number of plants. New research for TCHa and CBDa the raw forms of THC and CBD shows great potential for use as an anti-inflammatory, neuroprotectant and pain killer. In an exhaustive review, the National Academies of Science and Medicine recently confirmed the efficacy of cannabis for chronic pain in adults. Interestingly, when given access to cannabis, individuals currently using opioids for chronic pain decrease their use of opioids by 40–60% and report that they prefer cannabis to opioids. Cannabis is being used to successfully treat opioid addiction with resulting drops in overdose deaths. We should have this option in Kansas. THC continues to be vilified in Kansas for reasons I don’t understand because scientific research continues to show it is necessary for the synergistic healing effects within our bodies. In other words, it takes all the plant constituents to work in harmony to effect change within the body. It is true that a lot of cannabis plants contain higher THC content than ever before because the illicit growers were meeting consumer demands from the recreational market. As we continue to evolve treating disease with cannabis, we realized the importance of other cannabinoids. Plant breeders are working to bring back cultivar, (old cannabis strains) that contain lower THC levels and higher levels of other cannabinoids. This will be a wonderful opportunity for our Ag related colleges to take part in developing cannabis cultivar and researching plant constituents. Cannabis brings lifechanging healing to many but is not for everyone. There are some serious considerations patients will have to make before using cannabis. Some people simply can’t and should not use cannabis. This must be a personal decision made between the patient and physician not something dictated by the state. Cannabis trained physicians and nurses are aware of potential problems and work hard to educate patients so they can avoid untoward side effects. Access to tested, organic cannabis will also protect consumers from health complications seen when users consume contaminated illicit cannabis. I currently travel and teach a “Cannabis 101” class to nurses. I also have talked to hundreds of Kansans about cannabis over the last 2 years. Nurses are one of the most trusted medical professionals and as such people tell me a lot of things they would never admit to others because I don’t judge them or pose a threat by exposing their information. At all my classes I start by asking if attendees use any type of cannabis or know someone who uses cannabis for medical reasons. Consistently I have a 90% positive response. I ask people who admit they use cannabis where they are getting their cannabis from and I have discovered it comes from many sources. Some is obtained from licensed dispensaries from recreational states and is brought back in vehicles or by plane when returning home. Some comes from Kansans who grow cannabis and sell it to those who use it as medicine or recreationally. Some is obtained on the illicit market in legal states because the cost of tested products from dispensaries is more than people can afford. Some get cannabis from family members who live in legal states. Lastly, some grow plants at home and make cannabis products for themselves or family members. People have realized they can improve their health by using cannabis. Because patients must do all this in secret and alone without support, we are seeing problems that we would not see if they had guidance from medical professionals. We have concerns just as you do related to overuse syndrome, safety for self and community, prevention of child access as well as meeting educational needs of consumers. These concerns can be successfully addressed in our state just as they are successfully being addressed in other states. In the past we have heard concerns about children and teens having access to cannabis if we allow medical use. It is critical to remember medical cannabis products are not marketed for children, teens or the recreational market and we will need to educate parents and youth about cannabis safety. When you are presented with statistics please examine them and ask yourself if it is a statistic that reflects recreational use or medical use? Can medical cannabis products be diverted for recreational use? Of course, they can and that being said, it will be important to have stiff consequences for diverting medical products for illicit use.
Recommended publications
  • HOUSE BILL No. 2303
    Session of 2019 HOUSE BILL No. 2303 By Representatives Finney, Alcala, Ballard, Benson, Carlin, Carmichael, Clayton, Henderson, Highberger, Holscher, Horn, Moore, Ohaebosim, Ousley, Parker, Probst, S. Ruiz, Sawyer, Stogsdill, Victors, Warfield, Winn, Woodard and Xu 2-13 1 AN ACT enacting the Kansas safe access act; providing for the safe, legal, 2 humanitarian and therapeutic use of cannabis for medical conditions; 3 providing for the registration and functions of compassion centers; 4 authorizing the issuance of identification cards; establishing the 5 compassion board; providing for administration of the act by the 6 department of health and environment. 7 8 WHEREAS, Cannabis has been used as a medicine for at least 5,000 9 years and can be effective for serious medical conditions for which 10 conventional medications fail to provide relief; and 11 WHEREAS, Modern medical research has shown that cannabis can 12 slow the progression of such serious diseases as Alzheimer's and 13 Parkinson's, stop HIV and cancer cells from spreading; has both anti- 14 inflammatory and pain-relieving properties; can alleviate the symptoms of 15 epilepsy, post traumatic stress disorder and multiple sclerosis; is useful in 16 the treatment of depression, anxiety and other mental disorders; and can 17 help reverse neurological damage from brain injuries and stroke; and 18 WHEREAS, The world health organization has acknowledged the 19 therapeutic effects of cannabinoids, the primary active compounds found 20 in cannabis, including as an anti-depressant, appetite
    [Show full text]
  • The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
    TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM 3 The Rise and Decline of Cannabis Prohibition Authors Dave Bewley-Taylor Tom Blickman Martin Jelsma Copy editor David Aronson Design Guido Jelsma www.guidojelsma.nl Photo credits Hash Marihuana & Hemp Museum, Amsterdam/ Barcelona Floris Leeuwenberg Pien Metaal UNOG Library/League of Nations Archives UN Photo Printing Jubels, Amsterdam Contact Transnational Institute (TNI) De Wittenstraat 25 1052 AK Amsterdam Netherlands Tel: +31-(0)20-6626608 Fax: +31-(0)20-6757176 [email protected] www.tni.org/drugs www.undrugcontrol.info www.druglawreform.info Global Drug Policy Observatory (GDPO) Research Institute for Arts and Humanities Rooms 201-202 James Callaghan Building Swansea University Financial contributions Singleton Park, Swansea SA2 8PP Tel: +44-(0)1792-604293 This report has been produced with the financial www.swansea.ac.uk/gdpo assistance of the Hash Marihuana & Hemp Museum, twitter: @gdpo_swan Amsterdam/Barcelona, the Open Society Foundations and the Drug Prevention and Information Programme This is an Open Access publication distributed under (DPIP) of the European Union. the terms of the Creative Commons Attribution License The contents of this publication are the sole responsibility (http://creativecommons.org/licenses/by/2.0), which of TNI and GDPO and can under no circumstances be permits unrestricted use, distribution, and reproduction regarded as reflecting the position of the donors. in any medium, provided the original work is properly cited. TNI would appreciate receiving a copy of the text in which this document is used or cited.
    [Show full text]
  • Approved: February 29, 2012 MINUTES of the HOUSE
    Approved: February 29, 2012 MINUTES OF THE HOUSE HEALTH AND HUMAN SERVICES COMMITTEE The meeting was called to order by Chairperson Brenda Landwehr at 1:30 PM on Tuesday, January 24, 2012 in Room 784 of the Docking State Office Building. All members were present except: Representative Winn - Excused Representative Donohoe – Excused Representative Hermanson - Excused Committee staff present: Martha Dorsey, Kansas Legislative Research Department Joseph Leiker, Kansas Legislative Research Department Debbie Bartuccio, Committee Assistant Conferees appearing before the Committee: Representative Gail Finney (Attachments 1, 2 and 3) Dr. Eric Voth, M.D., FACP, Chairman, The Institute on Global Drug Policy (Attachments 4 and 5) Dr. Jon Hauxwell, Hays, Kansas (Attachments 6 and 7) Dan Dawdy (Attachment 8) Esau Freeman, Wichita, Kansas (Attachment 9) Philip Hornbeck, Haysville, Kansas (Attachment 10) Cheryl Riley, Voluntary Director, Kansas Medical Cannabis Network (Attachment 11) David Mulford, Hutchinson, Kansas (Attachment 12) Sarah Smith, Medically Retired Lenexa, Kansas Police Officer/Detective (Attachment 13) Jason Selmon, Kannabas Project Chairman (Attachment 14) Robin Lais, Wichita, Kansas (Attachment 15) Charles Weismiller, Acting Director, Kansas Chapter of the National Organization For the Reform of Marijuana Laws (Attachment 16) Nick Reinecker (Attachment 17) Michelle Voth, MPA, Executive Director, Kansas Family Partnership (Attachment 25) Max Wilson, Retired Executive Director of Shawnee Regional Prevention and Recovery Services (Attachment 26) Debby Moore, CEO, Hemp Industries of Kansas (Attachments 27 and 28) Others in attendance: See attached list. Unless specifically noted, the individual remarks recorded herein have not been transcribed verbatim. Individual remarks as reported herein have not been submitted to the individuals appearing before the committee for editing or corrections.
    [Show full text]
  • Dispensary Facility Final Score the Following Spreadsheet Reflects the Final Scores for All Dispensary Applicants
    Dispensary Facility Final Score The following spreadsheet reflects the final scores for all Dispensary applicants. Due to the size of the Dispensary applicant pool, DHSS is still preparing spreadsheets that reflect the level of detail in final score/rank that was provided for all other facility types. The Department expects to have this information posted the week of February 7. Congressional Location Zip District GIS Final Score (Sorted High to Low by License/Certification Applicant Entity Name Location Street Location City Location State Code Confirmed Congressional District) Status VMO-Ops, Inc. 3420 IOWA AVE SAINT LOUIS MO 63118 1 1705.09 Approved BeLeaf Medical LLC 6036 DELMAR BLVD SAINT LOUIS MO 63112 1 1651.91 Approved GF Wellness S. Grand LLC 3737 S GRAND BLVD SAINT LOUIS MO 63118 1 1645.04 Approved COMO HEALTH LLC 11088 NEW HALLS FERRY RD FLORISSANT MO 63136 1 1615.53 Approved FP4-Broadway LLC 8542 N BROADWAY SAINT LOUIS MO 63147 1 1610.83 Approved Agri-Genesis LLC 6407 MICHIGAN AVE SAINT LOUIS MO 63111 1 1610.44 Approved BeLeaf Medical LLC 2734 LAFAYETTE AVE SAINT LOUIS MO 63104 1 1609.14 Approved FP2-Natural Bridge LLC 4451 BROWN RD BERKELEY MO 63134 1 1598.50 Approved Heya St. Ann Retail II LLC 10417 SAINT CHARLES ROCK RD SAINT ANN MO 63074 1 1597.02 Approved TCAppliCO LLC 3230 PARKER RD FLORISSANT MO 63033 1 1596.60 Approved V3 Mo Vending 2, LLC 7766 N LINDBERGH BLVD HAZELWOOD MO 63042 1 1579.32 Approved COMO HEALTH LLC 5501 CHIPPEWA ST SAINT LOUIS MO 63109 1 1573.39 Approved 6662 Delmar SL, LLC 6662 DELMAR BLVD STE A UNIVERSITY
    [Show full text]
  • The Missouri Cannabis Industry Magazine Inside Missouri's First Facilities
    GREENWAY SEPTEMBER/OCTOBER 2020 GREENWAYTHE MISSOURI CANNABIS INDUSTRY MAGAZINE INSIDE MISSOURI’S FIRST FACILITIES P. 39 THE INFUSER MACHINE SHOWDOWN P. 20 on the cover MEET MORE MISSOURI BRANDSMOGREENWAY.COM 1 P. 27 MH&W Dispensary’s green cross, located inside CUTTING CULTIVATION COSTS P. 90 GREENWAY CHAIRMAN OF THE BOARD John Curtis | Beleaf (St. Louis) TRANSPORTATION, TECHNOLOGY HEALTHCARE, EDUCATION AND AND SECURITY COMMITTEE TRAINING COMMITTEE CULTIVATION Chair: Larry Ellison Co-Chair: Dr. Mimi Vo, MD CULTIVATION COMMITTEE Ozarx | CST Solutions (Springfield) (St. Louis) Bradford Goette Co-Chair: Cindy Northcutt, RN, BSN, JD Chair: John Mueller Nirvana | Bold Lane Transport (St. Louis) Kintsugi | Soulful Cannabis (SPR) Greenlight (Kansas City) GOVERNMENT MANUFACTURING Michael Allen Chip Sheppard AFFAIRS AND TESTING Chris McHugh 5th Meridian (Cape Girardeau) CECB Law (Springfield) Joseph Hollander Craft PC (Kansas City) Dacia Betts Hannah Bush David Alport MOCANNTrade G5 Express (St. Louis) Nirvana Investments (St. Louis) BOARD OF DIRECTORS Bridge City Collective | SLCC (KC/STL) Joe Delia Natalie Brown Mike Birkel Green Farms (St. Louis/Cuba) MoCann Testing - EKG Labs (Perryville) Birkel Electric (St. Louis) Kevin Ellison Zach Greene Brian Fox CST Solutions (Springfield) Quarter Coast Consulting (St. Louis) Greene Fox (St. Louis) HEALTHCARE, TRANSPORTATION, Allen Fortner Dr. Patricia Hurford, MD, MS EDUCATION AND TECHNOLOGY AND Susan Griffith TRAINING SECURITY Executive Security Specialists (Springfield) SOAR Medical (St Louis) CAMP (St. Louis) Tiffany Maggard Dr. Eboni January Mark Hendren Heffernan Insurance (Springfield) Greenlight Dispensary (STL/KC) Flora Farms (Joplin/Humansville) Joe Patterson Dena Ladd Ashley Picillo DISPENSARY Ceres Mgmt Group (St. Louis) Missouri Cures (St. Louis) Point 7 Group (Denver) Jim Regna Jennifer McGuire, LP John Wilbers Triad Bank (St.
    [Show full text]
  • Americans for Safe Access
    Americans for Safe Access ACTIVIST NEWSLETTER Defending Patients’ Access to Medical Marijuana APRIL 2018 Volume 14, Issue 4 Congress Acts to Protect Patients from Sessions until Sept Federal protections for medical from coming to a vote, and Attorney General tially long-term uptick in violent crime.” cannabis patients and those who Jeff Sessions has rescinded the Obama Sessions has long been a vocal critic of cannabis serve them in compliance with Administration’s guid - reform efforts. state law will continue uninter - ance to prosecutors that rupted after all, at least until the end of had discouraged prose - “The inclusion of the CJS Amendment in the September. Congress acted on March 23 to cutions. House budget shows that Congress knows it pass an appropriations bill that included the must protect medical cannabis patients. We Rohrabacher-Blumenauer amendment, which The amendment is the are extremely grateful to Represenatives for the fourth year prohibits the Department only thing that prevents federal raids and pros - Rohrabacher and Blumenauer and the other of Justice from interfering with state medical ecutions targeting businesses and individuals members that showed leadership on the cannabis programs. complying with state medical cannabis laws. issue." said Steph Sherer, Executive Director for Americans for Safe Access. “But this only buys The vote by the House of Representatives on Sessions lobbied to block the amendment. In a us a few months. We need comprehensive leg - the omnibus spending bill, which funds the May 2017 letter to Congress, he wrote: “I islation like the CARERS ACT.” government through September 30, 2018, believe it would be unwise for Congress to ended months of uncertainty, debate and con - restrict the discretion of the Department to Support for the amendment was strong and tinuing resolutions.
    [Show full text]
  • OMMA's List of Licensed Dispensaries
    LIST OF LICENSED DISPENSARIES As of September 22, 2021 NAME LICENSE No. EMAIL PHONE CITY ZIP COUNTY DAAA-Q4HM- HERBAL LEGENDS CULTIVATION LLC [email protected] 5809802065 ACHILLE 74720 BRYAN MG2P Trade Name: HERBAL LEGENDS CANNABIS STOP 5 BIG BOYS, LLC. DAAA-4KYJ-EJEV [email protected] 5805042711 ADA 74820 PONTOTOC Trade Name: RAILHEAD CANNABIS COMPANY 60 ACRE WOODS DISPENSARY LLC DENVER.KITCH@STABILITYCANNABI DAAA-69UX-MLCL 4052122270 ADA 74820 PONTOTOC Trade Name: STABILITY CANNABIS D19626 S.COM AAA RETAIL LLC DAAA-XUKB-6RTB [email protected] 5803996215 ADA 74820 PONTOTOC Trade Name: AAA RETAIL LLC AFFORDABLE CANNABIS LLC [email protected] DAAA-4YLJ-MSMT 5803202301 ADA 74820 PONTOTOC Trade Name: AFFORDABLE CANNABIS LLC OM ALL NATURAL SOLUTIONS LLC DAAA-7AIW-VKIL [email protected] 5802724041 ADA 74820 PONTOTOC Trade Name: ALL NATURAL SOLUTIONS CAIN'S CANNABIS DAAA-4KEO-TRND [email protected] 5802798435 ADA 74820 PONTOTOC Trade Name: 2 CAIN'S LLC COLECAMP INC FLOWERCHILDORGANICSADA@GM DAAA-EKJK-35PE 5805599220 ADA 74820 PONTOTOC Trade Name: COLECAMP INC DBA FLOWER CHILD ORGANICS AIL.COM DAWN'S LIGHT, LLC DAAA-4K8B-V6IS [email protected] 5802724305 ADA 74820 PONTOTOC Trade Name: DAWN'S LIGHT FLOWER-ON PRODUCTIONS, LLC FLOWERONPRODUCTIONS@GMAIL. DAAA-XH5T-95RJ 5804651769 ADA 74820 PONTOTOC Trade Name: FLOWER FACTORY FINE CANNABIS COM HAZE THERAPEUTICS LLC DAAA-4J26-L4KG [email protected] 5803993370 ADA 74820 PONTOTOC Trade Name: HAZE THERAPEUTICS LLC KSPM MEDICAL LLC DAAA-4JMT-NXSO [email protected] 4053712484 ADA 74820 PONTOTOC Trade Name: CBD PLUS USA NATIVE HARVEST LLC DAAA-EJNQ-IBYL [email protected] 4056065588 ADA 74820 PONTOTOC Trade Name: Oklahoma Medical Marijuana Authority OMMA.ok.gov Licensed Dispensaries | September 22, 2021 Page 1 of 160 NAME LICENSE No.
    [Show full text]
  • Insights from Cannabis Legalization
    Dissertation Public Health and Safety Consequences of Liberalizing Drug Laws Insights from Cannabis Legalization Steven Davenport This document was submitted as a dissertation in June 2020 in partial fulfillment of the requirements of the doctoral degree in public policy analysis at the Pardee RAND Graduate School. The faculty committee that supervised and approved the dissertation consisted of Gery Ryan (Chair), Jonathan Caulkins, and Beau Kilmer. Partial funding for this dissertation was provided by the James Q. Wilson Dissertation Award. PARDEE RAND GRADUATE SCHOOL For more information on this publication, visit http://www.rand.org/pubs/rgs_dissertations/RGSDA508-1.html Published 2020 by the RAND Corporation, Santa Monica, Calif. R® is a registered trademark Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions.html. The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. Support RAND Make a tax-deductible charitable contribution at www.rand.org/giving/contribute www.rand.org Abstract Cannabis has been legalized for non-medical purposes in Canada, Uruguay, eleven U.S.
    [Show full text]
  • Adinoff Testimony for Medical Cannabis in Kansas
    Bryon Adinoff, M.D. Adinoff Addiction Psychiatry, PLLC Addiction Psychiatry Consultant Oct 17, 2019 Special Committee on Federal and State Affairs Kansas Legislative Research Department Att’n Joanna Dolan 23 October, 2019; Room 346-S—Statehouse RE: S.366 Chairman Barker and committee members: Thank you for the opportunity to provide the Committee with my testimony supporting medical cannabis for Kansas. I am a Clinical Professor at the University of Colorado School of Medicine. I recently retired after 23 years as the Distinguished Professor of Alcohol and Drug Abuse Research at UT Southwestern Medical Center and over 30 years as an addiction psychiatrist in the Department of Veterans Affairs. I have published and spoken widely on the biological effects and treatment of addictive disorders (1) and I am the Editor of The American Journal of Drug and Alcohol Abuse (2). My research has been funded by the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Department of Veterans Affairs. Marijuana, or “botanical cannabis,” has several known cannabinoids that are potentially useful in a number of additional debilitating conditions. In a recent report, the National Academies of Medicine, Engineering, and Sciences reported that there was conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of chronic pain in adults and multiple sclerosis spasticity (3). JAMA Internal Medicine reported that states with medical marijuana laws saw a 25% decrease in opioid overdose deaths compared to states that did not have medical marijuana (4). This observation has been confirmed by other investigators.
    [Show full text]
  • In the Holton Recorder and Jackson County Shopper!
    THE HOLTON INSIDE SALUTE VFW Post TOPEKA, KAN. Hometown of 1367 Sara LaClair selling Holton Recorder subscriber fireworks. for 45 years. RECORDERServing the Jackson County Community for 153 years See ad on page 8. Volume 153, Issues 51 & 52 HOLTON, KANSAS • Mon./Wed. June 29 & July 1, 2020 20 Pages $1.00 New mask rule ‘Sale crew’ to lead Fair Parade By Brian Sanders ple who might have been for- for county may When the Jackson County gotten, or maybe they passed Fair was still being held at the on, or nobody thought about intersection of Fourth Street them, or whatever.” and Arizona Avenue in Hol- “It was nice of them to rec- be like Kelly’s ton, a group of dedicated vol- ognize us, though,” Hill add- unteers could be found in the ed. n fairgrounds arena every year, The duties of the five County commission sets Thursday helping to get cattle, sheep and men, among other volunteers meeting on governor’s executive order pigs into and out of the arena through the years, included for the fair’s annual livestock bringing livestock into and out Jackson County’s new guide- a press conference on Monday sale. of the show ring, then loading lines on wearing masks in public that to morrow, she would sign One of those volunteers, the animals into trucks that to pre vent the possible spread of an order re quiring that most Henry Hill — who started would take them to meat lock- COVID-19 (coronavirus) may Kansans in public spaces wear helping with the sale in the ers, if that was the animals’ in- not be exactly the same as what a mask, effective at 12:01 a.m.
    [Show full text]
  • Diy Infusion Tips with Blaze N Janes Safe Drug Use During
    EMERALD MAGAZINE MAGAZINE CANNABIS LIFESTYLE LIFESTYLE CANNABIS FABULOUS THEEMERALDMAGAZINE.COM FESTIVALS FROM COAST TO COAST SAFE DRUG USE DIY INFUSION DURING TIPS WITH FESTIVAL BLAZE N JANES SEASON THE WORLD’S MOST ADVANCED EXTRACTION EQUIPMENT MADE WITH PRECISION® #1 in Quality, Customer Service & Tech Support MULTI-SOLVENT EXTRACTION TECHNOLOGY PROCESS 100 TO 50,000+ LBS OF INPUT MATERIAL PER DAY! PRECISIONEXTRACTION.COM 855-420-0020 © 2019 PX2 Holdings, LLC. All rights reserved. PUBLISHER Christina E. De Giovanni MANAGING EDITOR Adolph Ward EDITOR-IN-CHIEF Dave Johnstone EDITOR-AT-LARGE Danielle Guercio COVER SHOT David Calderon ADVERTISEMENT DESIGN Nathan Wells GRAPHIC DESIGN Vero Avant RECIPE DESIGN Yedah Merino CANNABIS LIFESTYLE THE FESTIVAL LIFESTYLE GET CONNECTED TheEmeraldMagazine.com [email protected] Facebook.com/TheEmeraldMagazine Twitter.com/TheEmeraldNews Instagram.com/TheEmeraldMagazine ADVERTISING [email protected] Lee Moran, [email protected] Next Month’s Theme: The Infusion Lifestyle Published by Emerald Media Group Inc. P.O. Box 320057, San Francisco, CA 94132 © Emerald Media Group Inc. 2019 All rights are reserved. Reproduction in whole or in part without the written permission of Emerald Media Group Inc. is strictly forbidden. THE FESTIVAL LIFESTYLE ISSUE HE OST ISTINGS ALES IN UMBOLDT OUNTY From the TThe Experience, M KnowledgeL & Professionalism& S to MakeH Your Dreams C Come True Kyla Tripodi Publisher Broker/Owner #01930997 707.834.7979 Alderpoint - $719,000 FerndAle - $1,100,000
    [Show full text]
  • CANNABIS 101: the Who, What, When, Where, Whys, and Hows of Amendment 2’S Impact on Medical Marijuana in Missouri WHAT Is Cannabis?
    46th Annual Bench-Bar & Boardroom Conference Thursday, May 16, 2018 7:30 – 8:20 AM Cannabis 101 10.0 CLE Hours, Including 2.0 Ethics Hours in Missouri 10.0 CLE Hours, including 2.0 Ethics in Kansas 2300 Main Street, St. 100 ■ KC, MO 64108 ■ phone 816-474-4322 ■ fax 816-474-0103 Aubrey Gann-Redmon, AGR Legal Services, LLC EDUCATION Aubrey graduated summa cum laude from Avila University with a Bachelor of Arts degree in Sociology. She went on to obtain her Juris Doctorate degree from University of Missouri Kansas City School of Law, where she received the Order of the Barrister’s honor for excellence in trial advocacy. Aubrey also served on the staff of the ABA journal Urban Lawyer, and received the CALI Excellence in Learning Award for her academic work in the areas of Criminal Law and Gender & Justice. While in law school, Aubrey held internships where she worked on federal death penalty appeals, complex probate and trust litigation cases, and personal injury lawsuits. EXPERIENCE After law school, Aubrey was an associate at a boutique plaintiff’s personal injury firm where she worked on personal injury, employment discrimination, and social security disability cases. Currently, her practice focuses exclusively on cannabis law, as well as litigating estate, trust, and probate cases, with experience in both defending and prosecuting legal malpractice actions in the area of probate. COMMUNITY INVOLVEMENT & ACCOLADES Since starting AGR Legal Services, Aubrey has written and published numerous articles and taught classes and CLEs on probate and legal research techniques. Aubrey has also taught as an adjunct professor in the criminology department at Avila University.
    [Show full text]